deltatrials

Short bowel syndrome Trials in Copenhagen, Denmark

Conditions / Short bowel syndrome / Copenhagen, Denmark

Research into Short bowel syndrome spans multiple therapeutic approaches and trial phases.

16 total trials for this combination

Showing top 10 of 16 trials

Trials

NCT ID Title Status Phase
NCT00930644 Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS) COMPLETED PHASE3
NCT00172185 Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458) COMPLETED PHASE3
NCT07197944 Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS RECRUITING PHASE3
NCT05018286 Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. ACTIVE_NOT_RECRUITING PHASE3
NCT04627025 Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF COMPLETED PHASE3
NCT00081458 Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome COMPLETED PHASE3
NCT03905707 Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS ACTIVE_NOT_RECRUITING PHASE3
NCT00798967 Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects COMPLETED PHASE3
NCT04775706 Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects RECRUITING
NCT03690206 Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) COMPLETED PHASE3

Related Pages